MUMBAI, India, July 13 -- Intellectual Property India has published a patent application (202617076016 A) filed by Nurix Therapeutics, Inc. on June 19, 2026, for Compounds Useful In The Modulation Of Klhdc1 And Klhdc2 Activity.
Inventors include Landstrom, Evan, B.; Malone, Marie, L.; Pemberton, Ryan; and Wu, Jeffrey.
The application for the patent was published on July 10, 2026, under issue no. 28/2026.
Abstract: This disclosure relates to compounds useful for ex vivo, in vitro, or in vivo modulation of KLHDC1 and KLHDC2 activity. This disclosure also provides pharmaceutically acceptable compositions comprising said compounds, and methods of using the compositions in the treatment of various diseases, conditions, and/or disorders.
Disclaimer: Curated by HT Syndication.
